Simulations Plus

company

About

Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET).

  • 51 - 100

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.70M
Industries
Biotechnology,Computer,Data Mining,Enterprise Software,Information Technology,Life Science,Software
Founded date
Jan 1, 1996
Number Of Employee
51 - 100
Operating Status
Active

Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, generics, chemical, cosmetic, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions... sooner.

Founded in 1996, Simulations Plus employs over 60 employees and is publicly-traded on the NASDAQ stock exchange (ticker symbol = SLP).Our headquarters are based in Lancaster, California, with our pharmacometrics consulting team located in Buffalo, New York. Trusted distributors handle sales and scientific support in Asian territories. 19 of the top 20 pharmaceutical companies, plus numerous mid- and small-sized companies and all major regulatory agencies, license our modeling & simulation technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.70M
Simulations Plus has raised a total of $1.70M in funding over 2 rounds. Their latest funding was raised on Mar 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2022 Grant $1.70M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Simulations Plus is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant